Summary & Overview
CPT 0603T: Fluorescent Sensor Measurement of Glomerular Filtration Rate
CPT code 0603T describes a diagnostic service that measures glomerular filtration rate (GFR) by placing a proprietary skin sensor and injecting a fluorescent pyrazine agent while a monitor displays renal function. This emerging technique provides a direct, device-assisted assessment of renal clearance and may affect clinical decision-making for acute and chronic kidney conditions. Nationally, the code represents an advanced diagnostic modality with implications for outpatient nephrology, diagnostic imaging centers, and hospital outpatient departments.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what the code represents, payer coverage context, and expected clinical settings. The publication also summarizes benchmarks and utilization trends where available, highlights any recent policy or coding guidance that affects billing and claims processing, and places the procedure in clinical context relative to conventional GFR assessment methods.
This summary is intended for billing managers, reimbursement analysts, and clinical program leads who need a concise understanding of CPT code 0603T, its service implications, and the payer landscape for national planning and policy considerations.
Billing Code Overview
CPT code 0603T describes a procedure in which the provider places a proprietary sensor device on the patient’s skin, injects a fluorescent pyrazine agent, and uses a monitor to display the glomerular filtration rate (GFR), a measure of renal function. The description specifies that the provider administers more than one dose in a 24–hour period.
-
Service type: Diagnostic renal function measurement using a topical sensor and injected fluorescent agent
-
Typical site of service: Outpatient facility or clinic setting where sensor placement and intravenous or subcutaneous injection and monitored imaging/measurement can be performed
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with suspected or known acute or chronic kidney dysfunction who requires a point-of-care, quantitative measurement of glomerular filtration rate (GFR). The patient presents to an outpatient infusion suite, ambulatory clinic, or hospital setting for functional renal assessment when serum creatinine and estimated GFR are insufficient for clinical decision-making (for example, in patients with rapidly changing renal function, morbid obesity, cachexia, or when precise measured GFR is required for chemotherapy dosing or pre-transplant evaluation). The provider places a proprietary, noninvasive sensor on the patient’s skin and injects a fluorescent pyrazine agent intravenously. A monitor records fluorescence clearance and displays a measured GFR. The code describes administration of more than one dose in a 24‑hour period; this occurs when multiple serial measurements are clinically required (for example, to track rapidly changing renal function during nephrotoxic therapy, immediately postoperatively, or when repeat confirmation is needed for transplant evaluation). Typical workflow: obtain informed consent and IV access, place sensor, administer the agent, monitor clearance on the device, document device placement, agent dosing times and volumes, measured GFR result(s), and any adverse events. Typical sites of service: outpatient infusion center, ambulatory specialty clinic, emergency department, inpatient ward, or preoperative assessment unit. Typical personnel: nephrologist or supervising clinician, trained nurse or technologist to place sensor and administer agent, and device technician or trained staff to operate the monitor. Billing considerations include use of 0603T for each service day when more than one dose is administered within a 24‑hour period and documentation supporting medical necessity for repeat dosing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | When the work required to perform the test is substantially greater than typically required and documentation supports increased effort (e.g., complex IV access or prolonged monitoring). |
51 | Multiple procedures | When this test is billed the same day with other distinct procedures and payer policy requires reporting of multiple procedures. |
52 | Reduced services | When the procedure was partially reduced or not completed as planned (e.g., incomplete administration of planned doses). |
53 | Discontinued procedure | When the procedure is started but discontinued due to unforeseen circumstances (e.g., hypersensitivity to the agent). |
54 | Surgical care only | If the provider bills only for the procedural portion distinct from pre/post care (rare for this test). |
55 | Postoperative management only | If only post‑procedure management is billed separately by a different provider. |
62 | Two surgeons | When two surgeons or clinicians from the same specialty perform distinct parts of the procedure requiring documentation. |
QK | Medical direction of two, three, or four individuals | When the reporting physician medically directs multiple (2–4) qualified personnel performing the service. |
QX | Modifier for assistant-at-surgery requirements (assistant not personally performing direction) | When a certified surgical assistant performs an assisting role and payer requires this modifier. |
QY | Medical direction of one physician by another physician | When a physician directs a single auxiliary staff member performing the test under direct medical direction. |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery | If such an allied provider assists in the procedure and payer allows reporting. |
CO | Out-of-country | When the service is provided outside the United States and reported to payers recognizing this modifier. |
CQ | Routine clinical service provided by a CRNA | When a certified registered nurse anesthetist provides routine clinical services related to the procedure and payer requires this modifier. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 2080P0800X | Nephrology | Nephrologists commonly order, interpret, and supervise measured GFR testing. |
| 207RE0101X | Radiology (Diagnostic) | Diagnostic radiology or imaging specialists may oversee noninvasive sensor-based functional testing when performed in imaging suites. |
| 363L00000X | Clinical Laboratory | Laboratory medicine or clinical chemistry specialists may be responsible for quality control and reporting of measured GFR devices. |
| 163W00000X | Hospitalist | Hospitalists commonly order and interpret point-of-care measured GFR in inpatient settings. |
| 207K00000X | Internal Medicine | Internists and subspecialists managing dosing and renal monitoring frequently use this test. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
N18.3 | Chronic kidney disease, stage 3 (moderate) | Measured GFR informs staging and management decisions in moderate CKD when eGFR estimates are uncertain. |
N18.4 | Chronic kidney disease, stage 4 (severe) | Precise GFR measurement guides timing of nephrology referral, medication adjustment, and transplant evaluation. |
N18.5 | Chronic kidney disease, stage 5 | Used when monitoring progressive decline and to assess need for renal replacement therapy planning. |
R79.89 | Other specified abnormal findings of blood chemistry | Abnormal renal biomarkers may prompt direct measurement of GFR for clarification. |
T82.7XXA | Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, initial encounter | Included as an example of complex patients with devices who may need accurate GFR for medication dosing; device-based monitoring may be coordinated in such cases. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
0603T | Placement of proprietary sensor on skin and injection of fluorescent pyrazine agent with monitor display of glomerular filtration rate; more than one dose in a 24‑hour period | Primary code for the described measured GFR service when multiple doses are administered within 24 hours. |
96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | May be billed when IV hydration is provided as part of procedural preparation or recovery, per payer policy. |
36415 | Collection of venous blood by venipuncture | Often performed for concurrent serum creatinine, BUN, or confirmatory laboratory testing during the same encounter. |
95250 | Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; sensor placement, hookup, patient training, and device calibration as necessary | Conceptually similar workflow for sensor placement and patient education; included here for ancillary comparison of sensor-based monitoring services. |
99070 | Supplies and materials (e.g., sterile tray, devices) used during the procedure, not otherwise reported | Used to report additional disposable supplies or proprietary sensor components when payer policy allows. |